March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
A Stable Chitosan-coated Nanomicelle Combination Of Vitamin E-TPGS And Cholesterol-PEG For The Topical Administration And Scleral Retention Of Rapamycin
Author Affiliations & Notes
  • Naba Elsaid
    Kings College Hospital, London, United Kingdom
  • Zeeneh Elsaid
    The School of Pharmacy, University of London, London, United Kingdom
  • Satyanarayana Somavarapu
    The School of Pharmacy, University of London, London, United Kingdom
  • Timothy L Jackson
    Kings College Hospital, London, United Kingdom
  • Footnotes
    Commercial Relationships  Naba Elsaid, None; Zeeneh Elsaid, None; Satyanarayana Somavarapu, None; Timothy L Jackson, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 328. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Naba Elsaid, Zeeneh Elsaid, Satyanarayana Somavarapu, Timothy L Jackson; A Stable Chitosan-coated Nanomicelle Combination Of Vitamin E-TPGS And Cholesterol-PEG For The Topical Administration And Scleral Retention Of Rapamycin. Invest. Ophthalmol. Vis. Sci. 2012;53(14):328.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The aim of this study was to prepare and characterise chitosan-coated vitamin E-TPGS: cholesterol-PEG (CPEG) nanomicelles and use these in the ocular delivery of the insoluble, hydrophobic drug rapamycin.

Methods: : Micelles containing vitamin E-TPGS and cholesterol-PEG (CPEG) were prepared and coated with chitosan oligomer using the thin film method. This formulation was analysed for encapsulation efficiency, size and stability (Dynamic Light Scattering- DLS), surface morphology (Transmission Electron Microscopy- TEM) and critical micelle concentration (fluorometry). Furthermore, ex-vivo studies were conducted by mounting porcine sclera in Ussing chambers and measuring the drug content which was retained in and had permeated across the sclera. Sample analysis was carried out using High Performance Liquid Chromatography with a limit of quantification (LOQ) of 12.5ng/mL.

Results: : The TPGS:CPEG micelles successfully entrapped rapamycin with an encapsulation efficiency of 78% and a desirable size of 13nm. These micelles remained stable for 7 days, unlike the TPGS micelles which were stable for 3 days. The solution was visibly clear with a polydispersity index of 0.07 and no sign of aggregates. TEM and DLS data confirmed this and showed uniform particle distribution. The critical micelle concentration was found to be 1x10-4% w/v. The addition of CPEG and the chitosan coating of these micelles enabled permeation within the first 30 minutes of tissue exposure and caused a significant increase in scleral retention.

Conclusions: : A stable nanomicellar formulation was developed with desirable physiochemical properties and transscleral permeation which occurred within the first 30 minutes of tissue exposure. Furthermore, there is potential for future applications in topical drug delivery as this formulation was retained in the sclera. This carrier system may also enhance the transscleral delivery of drugs that may otherwise not be able to target the posterior segment of the eye.

Keywords: sclera • inflammation • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×